Abbott (ABT) PT Jumps To $74 From $68 On Organic Revenue Growth Acceleration - Jefferies
Tweet Send to a Friend
Jefferies analyst, Raj Denhoy, reiterated his Buy rating on shares of Abbott Labs (NYSE: ABT) and raised his price target ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


